Beiersdorf, the German group behind brands such as Nivea, Labello, and La Prairie, reported 2% organic growth in its consumer goods division during the first nine months of the year. However, in nominal terms, sales remained at the previous year’s level of EUR 6.3 billion.
In the first nine months of 2025, Nivea recorded organic sales growth of 0.6%, reflecting “a continued slowdown in the mass market, especially in Latin America and Eastern Europe,” according to Beiersdorf.
In order to attract customers willing to pay for breakthrough innovations, the brand has launched a series of market firsts such as the Cellular Epigenetics Rejuvenating Serum, the first epigenetic serum for the mass market.
Beiersdorf’s sales were mainly driven by its dermo-cosmetic brands — Eucerin and Aquaphor — that continued to win market share across regions. In the first nine months, the group’s Derma business organic sales grew 12.3%, despite a tough comparison base from last year.
The La Prairie luxury brand recorded a 7.2% decline in organic sales in the first nine months of 2025 but returned to growth in the third quarter with organic sales growth of 1.6%.
Eventually, Beiersdorf’s Health Care business, which includes the Hansaplast and Elastoplast brands, achieved strong organic sales growth of 8.8% in the first nine months of 2025.
Due to slowing sales in its core skincare segment, the group has revised its 2025 growth forecast downward.
“We saw a further deceleration of the skin care market in the third quarter of 2025 especially in emerging markets, which is why we now expect an organic sales growth for our Consumer business of around 2.5% for the full year,” said Beiersdorf CEO, Vincent Warnery.
